1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Meniere Disease Global Clinical Trials Review, H2, 2015

Meniere Disease Global Clinical Trials Review, H2, 2015

  • August 2015
  • -
  • Global Data
  • -
  • 70 pages

Meniere Disease Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Meniere Disease Global Clinical Trials Review, H2, 2015" provides an overview of Meniere Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Meniere Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Meniere Disease Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Meniere Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Meniere Disease 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Meniere Disease Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Meniere Disease 29
May 21, 2015: Otonomy Reports Phase 2b Topline Data for OTO-104 in Meniere's Disease 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Otonomy, Inc. 30
Clinical Trial Overview of Otonomy, Inc. 30
Abbott Laboratories 31
Clinical Trial Overview of Abbott Laboratories 31
UMC Utrecht 32
Clinical Trial Overview of UMC Utrecht 32
Synphora AB 33
Clinical Trial Overview of Synphora AB 33
Rho, Inc. 34
Clinical Trial Overview of Rho, Inc. 34
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Lambda Therapeutic Research Ltd. 36
Clinical Trial Overview of Lambda Therapeutic Research Ltd. 36
Cromsource Srl 37
Clinical Trial Overview of Cromsource Srl 37
Buffalo ENT Specialists, LLP 38
Clinical Trial Overview of Buffalo ENT Specialists, LLP 38
Clinical Trial Overview of Top Institutes / Government 39
Tehran University of Medical Sciences 39
Clinical Trial Overview of Tehran University of Medical Sciences 39
Chi Mei Medical Center 40
Clinical Trial Overview of Chi Mei Medical Center 40
Gifu University 41
Clinical Trial Overview of Gifu University 41
House Research Institute 42
Clinical Trial Overview of House Research Institute 42
Kitasato University Oriental Medicine Research Center 43
Clinical Trial Overview of Kitasato University Oriental Medicine Research Center 43
Osaka University 44
Clinical Trial Overview of Osaka University 44
UMC Utrecht Holding BV 45
Clinical Trial Overview of UMC Utrecht Holding BV 45
Five Key Clinical Profiles 46
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 70

List of Tables
Meniere Disease Therapeutics, Global, Clinical Trials by Region, 2015* 7
Meniere Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Meniere Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Meniere Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Meniere Disease Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11
Meniere Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Meniere Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 14
Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 17
Meniere Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Meniere Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 19
Meniere Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20
Meniere Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Meniere Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Meniere Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 23
Meniere Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Meniere Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Meniere Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Meniere Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Meniere Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Otonomy, Inc., 2015* 30
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 31
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2015* 32
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Synphora AB, 2015* 33
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Rho, Inc., 2015* 34
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 35
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Lambda Therapeutic Research Ltd., 2015* 36
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cromsource Srl, 2015* 37
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Buffalo ENT Specialists, LLP, 2015* 38
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 39
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chi Mei Medical Center, 2015* 40
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Gifu University, 2015* 41
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by House Research Institute, 2015* 42
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kitasato University Oriental Medicine Research Center, 2015* 43
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015* 44
Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2015* 45

List of Figures
Meniere Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Meniere Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Meniere Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Meniere Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Meniere Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11
Meniere Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 14
Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 17
Meniere Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
Meniere Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19
Meniere Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20
Meniere Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Meniere Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Meniere Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Meniere Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Meniere Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Meniere Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 68

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.